Results 211 to 217 of about 1,392 (217)

SpectronRX plans actinium-225 in Indiana

Chemical & Engineering News, 2022
openaire   +1 more source

Targeted actinium-225 in vivo generators for therapy of ovarian cancer.

Cancer research, 2003
Advanced ovarian cancer is largely incurable, but initially it is frequently confined to the i.p. space. We explored i.p. radioimmunotherapy in a mouse model of human ovarian cancer. Use of a targeted actinium-225 ((225)Ac) in vivo generator of alpha particles exploits the extreme, selective cytotoxicity of alpha particles, while providing a feasible ...
Paul E, Borchardt, Rui R, Yuan, Matthias, Miederer, Michael R, McDevitt, David A, Scheinberg   +4 more
openaire   +1 more source

Entwicklung alternativer Verbindungen für die PSMA-Therapie mit Actinium-225

Nuklearmedizin - NuclearMedicine, 2023
Reissig, F., Zarschler, K., Novy, Z., Petrik, M., Pietzsch, H.-J., Kopka, K., Mamat, C.   +6 more
openaire   +2 more sources

Bispidine - One chelator to bind lutetium-177 and actinium-225

Nuclear Medicine and Biology, 2023
Santiago Brühlmann, Manja Kubeil, Patrick Cieslik, Ina Kopp, Michael Bachmann, Klaus Kopka, Stephan Holger, Peter Comba   +7 more
openaire   +1 more source

Actinium-225-DOTATATE

Reactions Weekly
openaire   +1 more source

US DOE tri-lab effort to produce actinium-225

Nuclear Medicine and Biology, 2019
openaire   +1 more source

Actinium-225-DOTA-LM3/Lutetium-177-DOTA-LM3

Reactions Weekly
openaire   +1 more source